Product Information
UBRELVY 100 MG TABLET is a brand product labeled by Allergan, Inc., priced at $109.1802 per EA under NDC 00023650110. Its NADAC has been published 328 times since Mar 18, 2020.
Strength
100 mg/1
Manufacturer
Allergan, Inc.NDC
00023650110
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
UBROGEPANTApproval Type
New Drug (NDA)
FDA Application
NDA211765On Market Since
12/23/2019
Pharmacological Classes
Price Statistics
The NADAC for UBRELVY 100 MG TABLET has been published 328 times since Mar 18, 2020, and over the history we have for it it has risen 34.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $109.1802 per EA |
|---|---|
| All-time high | $109.1882 (May 13, 2026) |
| All-time low | $81.4655 (Mar 18, 2020) |
| 52-week high | $109.1882 |
| 52-week low | $103.9379 |
| Median price | $94.5101 |
| Average price | $94.0079 |
| Largest weekly change | +5.0% (Feb 2, 2022) |
| Weeks tracked | 328 |
| Tracking since | Mar 18, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of UBRELVY 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for UBRELVY 100 MG TABLET, manufactured by Allergan, Inc., is $109.1802 per EA (NDC 00023650110), effective Jun 24, 2026.
How has the price of UBRELVY 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for UBRELVY 100 MG TABLET has risen 34.0%. It has been tracked across 328 weekly CMS publications since Mar 18, 2020.
What are the highest and lowest recorded NADAC prices for UBRELVY 100 MG TABLET?
Since Mar 18, 2020, the NADAC for UBRELVY 100 MG TABLET has ranged from a low of $81.4655 (Mar 18, 2020) to a high of $109.1882 (May 13, 2026), with a median of $94.5101 per EA.
Are there cheaper alternatives to UBRELVY 100 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as UBRELVY 100 MG TABLET, but none are currently priced below it.
Who manufactures UBRELVY 100 MG TABLET?
UBRELVY 100 MG TABLET (NDC 00023650110) is labeled by Allergan, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification